Stock Events

Stock Events

Pulse Biosciences 

$22
0
+$1.79+8.86% Today

Statistics

Day High
22
Day Low
20.2
52W High
-
52W Low
-
Volume
26
Avg. Volume
-
Mkt Cap
1.5B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7MayExpected
Q3 2025
Q4 2025
Next
-0.31
-0.27
-0.23
-0.18
Expected EPS
-0.27
Actual EPS
N/A

Financials

-20,794.57%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
700,000Revenue
-145.56MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PLSE.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific Corporation offers a wide range of medical devices that compete in the cardiovascular and neuromodulation markets, overlapping with Pulse Biosciences' therapeutic areas.
Medtronic
MDT
Mkt Cap116.33B
Medtronic is a global leader in medical technology, services, and solutions, competing across several of Pulse Biosciences' key areas, including cardiac and vascular therapies.
Intuitive Surgical
ISRG
Mkt Cap189.4B
Intuitive Surgical, known for its da Vinci surgical systems, competes with Pulse Biosciences in the field of minimally invasive surgery, albeit through different technological approaches.
Stryker
SYK
Mkt Cap136.19B
Stryker is a medical technologies firm that competes with Pulse Biosciences in the development of surgical and neurotechnology products.
Zimmer Biomet
ZBH
Mkt Cap19.92B
Zimmer Biomet Holdings, Inc. competes in the musculoskeletal healthcare sector, offering products that can be seen as alternatives to Pulse Biosciences' treatments.
Edwards Lifesciences
EW
Mkt Cap48.41B
Edwards Lifesciences specializes in heart valves and hemodynamic monitoring, competing with Pulse Biosciences in the broader field of medical devices for cardiovascular health.
Hologic
HOLX
Mkt Cap16.45B
Hologic, Inc. focuses on diagnostics, medical imaging systems, and surgical products for women's health, competing with Pulse Biosciences in the medical device market.
Baxter International
BAX
Mkt Cap9.49B
Baxter International Inc. provides a broad portfolio of renal and hospital products, including bio-surgery products that compete with Pulse Biosciences' offerings in the surgical market.

About

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
Show more...
CEO
ISIN
US74587B1017

Listings

F
DE
6L8.F
XNAS
US
PLSE
BOATS
BOATS
PLSE.BOATS

0 Comments

Share your thoughts

FAQ

What is Pulse Biosciences stock price today?▼
The current price of PLSE.BOATS is $22 USD — it has increased by +8.86% in the past 24 hours. Watch Pulse Biosciences stock price performance more closely on the chart.
What is Pulse Biosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Pulse Biosciences stocks are traded under the ticker PLSE.BOATS.
What is Pulse Biosciences market cap?▼
Today Pulse Biosciences has the market capitalization of 1.5B
When is the next Pulse Biosciences earnings date?▼
Pulse Biosciences is going to release the next earnings report on May 07, 2026.
What were Pulse Biosciences earnings last quarter?▼
PLSE.BOATS earnings for the last quarter are -0.18 USD per share, whereas the estimation was -0.27 USD resulting in a +31% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Pulse Biosciences revenue for the last year?▼
Pulse Biosciences revenue for the last year amounts to 700,000 USD.
What is Pulse Biosciences net income for the last year?▼
PLSE.BOATS net income for the last year is -145.56M USD.
When did Pulse Biosciences complete a stock split?▼
Pulse Biosciences has not had any recent stock splits.